Ignite Creation Date:
2025-12-24 @ 11:58 PM
Ignite Modification Date:
2025-12-25 @ 9:55 PM
Study NCT ID:
NCT05238558
Status:
COMPLETED
Last Update Posted:
2023-09-21
First Post:
2022-01-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Safety and Immune Response to FMPV-1
Sponsor:
Hubro Therapeutics AS
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-01-31
Start Date Type:
ACTUAL
Primary Completion Date:
2022-10-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-06-30
Completion Date Type:
ACTUAL
First Submit Date:
2022-01-26
First Submit QC Date:
None
Study First Post Date:
2022-02-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-20
Last Update Post Date:
2023-09-21
Last Update Post Date Type:
ACTUAL